Suppr超能文献

两种新型抗人诱导性共刺激配体单克隆抗体的免疫反应性

Immunoreactivity of two novel monoclonal antibodies against human inducible co-stimulator ligand.

作者信息

Shen Shuang, Wang Fengming, Chen Liwen, Wang Ting, Hu Yumin, Zhang Xueguang

机构信息

Institute of Medical Biotechnology, Soochow University, 708 Renmin Road, Suzhou, China.

出版信息

Hybridoma (Larchmt). 2011 Aug;30(4):361-8. doi: 10.1089/hyb.2011.0014.

Abstract

Human inducible co-stimulator ligand (GL50, CD275), also known as B7-H2 or ICOSL, is a positive co-stimulatory molecule of B7/CD28 superfamily, which plays a critical role in immune response. Here we generated two novel mouse anti-human GL50 monoclonal antibodies (MAbs) using classical hybridoma technology. The two MAbs (clones 2B4 and 4D11) were IgG1 (κ) and IgG2a (κ), respectively, and bound specifically to human GL50. Epitope competition assay showed that 2B4 and 4D11 bind to the same epitope of GL50, which is not recognized by the commercially available GL50 MAb (9F-8A4). Functionally, the two MAbs act as a blocker of T cell proliferation. Taken together, as useful tools, these two antibodies might be of great value for further exploration of the immune identification and function of GL50.

摘要

人诱导性共刺激分子配体(GL50,CD275),也称为B7-H2或ICOSL,是B7/CD28超家族的一种正向共刺激分子,在免疫反应中起关键作用。在此,我们利用经典杂交瘤技术制备了两种新型小鼠抗人GL50单克隆抗体(MAb)。这两种单克隆抗体(克隆2B4和4D11)分别为IgG1(κ)和IgG2a(κ),并与人GL50特异性结合。表位竞争试验表明,2B4和4D11与GL50的同一表位结合,而市售的GL50单克隆抗体(9F-8A4)不识别该表位。在功能上,这两种单克隆抗体可作为T细胞增殖的阻滞剂。综上所述,作为有用的工具,这两种抗体对于进一步探索GL50的免疫识别和功能可能具有重要价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验